Header Logo

Nicola Klein

Concepts (458)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Vaccination
116
2025
655
12.880
Why?
Influenza Vaccines
49
2025
273
10.860
Why?
Influenza, Human
36
2025
265
9.400
Why?
Vaccines
36
2025
218
6.700
Why?
Diphtheria-Tetanus-acellular Pertussis Vaccines
25
2025
88
5.790
Why?
Whooping Cough
17
2023
66
5.710
Why?
Humans
254
2025
17822
5.520
Why?
Child
97
2025
2497
5.150
Why?
Immunization
19
2025
70
4.510
Why?
Infant
78
2025
1198
4.160
Why?
Hospitalization
35
2025
810
3.900
Why?
Measles-Mumps-Rubella Vaccine
13
2022
62
3.890
Why?
Female
165
2025
12780
3.850
Why?
Meningococcal Vaccines
11
2022
39
3.800
Why?
Chickenpox Vaccine
18
2022
91
3.740
Why?
Adolescent
86
2025
3690
3.470
Why?
Child, Preschool
61
2025
1424
3.420
Why?
Male
122
2025
10145
3.340
Why?
Immunization Schedule
21
2024
122
3.170
Why?
Pregnancy Complications, Infectious
16
2025
146
2.990
Why?
Measles
6
2022
24
2.890
Why?
Antibodies, Bacterial
19
2023
33
2.850
Why?
Product Surveillance, Postmarketing
16
2018
95
2.810
Why?
Adult
101
2025
7708
2.770
Why?
Papillomavirus Vaccines
13
2024
113
2.730
Why?
Seizures, Febrile
8
2022
42
2.670
Why?
Young Adult
70
2025
2464
2.640
Why?
Vaccines, Combined
21
2023
80
2.540
Why?
Vaccination Coverage
10
2025
45
2.530
Why?
United States
73
2025
4007
2.500
Why?
California
44
2025
2328
2.430
Why?
Pericarditis
3
2022
11
2.400
Why?
Myocarditis
3
2022
14
2.400
Why?
Retrospective Studies
56
2025
2467
2.330
Why?
Vaccines, Conjugate
18
2023
59
2.260
Why?
Poliovirus Vaccine, Inactivated
9
2020
21
2.250
Why?
Incidence
34
2024
1269
2.110
Why?
Pneumococcal Infections
7
2023
42
2.090
Why?
Herpes Zoster
6
2023
82
2.010
Why?
Herpes Zoster Vaccine
6
2023
59
2.010
Why?
Pneumococcal Vaccines
10
2025
66
1.950
Why?
Papillomavirus Infections
11
2024
139
1.930
Why?
Immunization, Secondary
14
2022
57
1.920
Why?
Meningococcal Infections
7
2019
17
1.870
Why?
Pregnancy
41
2025
1529
1.870
Why?
Fever
7
2022
55
1.860
Why?
Emergency Service, Hospital
15
2025
368
1.860
Why?
Drug-Related Side Effects and Adverse Reactions
19
2017
107
1.820
Why?
Diphtheria-Tetanus-Pertussis Vaccine
8
2020
23
1.810
Why?
Pregnancy Outcome
8
2025
158
1.780
Why?
Immunogenicity, Vaccine
7
2024
12
1.720
Why?
Infant, Newborn
31
2025
858
1.650
Why?
Pertussis Vaccine
6
2020
14
1.640
Why?
Cohort Studies
38
2023
2590
1.620
Why?
Pneumonia, Pneumococcal
2
2023
13
1.610
Why?
Haemophilus Vaccines
6
2020
17
1.600
Why?
Vaccines, Inactivated
10
2023
67
1.590
Why?
Vaccines, Synthetic
9
2024
34
1.590
Why?
Mumps
3
2020
12
1.570
Why?
Neuralgia, Postherpetic
2
2023
12
1.520
Why?
Middle Aged
49
2025
8020
1.440
Why?
Adverse Drug Reaction Reporting Systems
20
2021
93
1.400
Why?
Disease Outbreaks
5
2020
36
1.390
Why?
Antibodies, Viral
13
2024
65
1.380
Why?
Time Factors
23
2022
1097
1.330
Why?
Guillain-Barre Syndrome
4
2022
15
1.330
Why?
Case-Control Studies
24
2024
1120
1.320
Why?
Aged
35
2025
6173
1.290
Why?
Rotavirus Vaccines
9
2025
52
1.090
Why?
Immunization Programs
7
2025
65
1.060
Why?
Vaccination Refusal
3
2020
9
1.030
Why?
RNA, Messenger
11
2024
72
1.010
Why?
Neisseria meningitidis
4
2019
10
1.000
Why?
Abortion, Spontaneous
7
2023
47
1.000
Why?
Intensive Care Units, Neonatal
3
2011
41
0.980
Why?
Pneumonia
2
2023
51
0.940
Why?
Herpesvirus 3, Human
5
2023
44
0.940
Why?
Prenatal Care
4
2020
130
0.910
Why?
Herpes Zoster Ophthalmicus
1
2023
1
0.890
Why?
Seasons
10
2025
105
0.860
Why?
Tetanus
5
2023
17
0.850
Why?
Measles Vaccine
3
2022
17
0.830
Why?
Autoimmune Diseases
3
2012
20
0.820
Why?
Adaptive Immunity
1
2022
1
0.800
Why?
Sepsis
2
2015
70
0.790
Why?
Premature Birth
8
2023
137
0.780
Why?
Vaccines, Attenuated
10
2023
45
0.780
Why?
Risk Assessment
16
2020
1103
0.780
Why?
Immunologic Factors
1
2022
29
0.780
Why?
Cluster Analysis
3
2023
90
0.780
Why?
Influenza A Virus, H1N1 Subtype
7
2024
52
0.780
Why?
Seizures
4
2014
29
0.750
Why?
Communicable Disease Control
2
2011
18
0.750
Why?
Asthma
4
2022
387
0.740
Why?
Streptococcus pneumoniae
7
2023
19
0.730
Why?
Rubella
1
2020
6
0.720
Why?
Influenza A virus
2
2020
13
0.710
Why?
Follow-Up Studies
11
2020
1219
0.700
Why?
Hearing Loss, Sensorineural
2
2020
7
0.700
Why?
Education, Medical, Continuing
1
2020
30
0.690
Why?
Eggs
1
2020
8
0.690
Why?
Family Practice
1
2020
45
0.690
Why?
Risk Factors
17
2024
3362
0.690
Why?
Blood Bactericidal Activity
6
2019
10
0.680
Why?
Autism Spectrum Disorder
2
2022
164
0.670
Why?
Aged, 80 and over
16
2025
1931
0.650
Why?
Logistic Models
9
2020
928
0.650
Why?
Diphtheria
4
2016
13
0.640
Why?
Chorioamnionitis
4
2023
18
0.640
Why?
Stillbirth
5
2024
29
0.630
Why?
Pediatrics
1
2020
161
0.620
Why?
Data Collection
7
2021
257
0.610
Why?
Infant, Premature
2
2010
60
0.610
Why?
Risk
14
2021
518
0.610
Why?
Ambulatory Care
5
2024
247
0.610
Why?
Antibody Formation
1
2018
7
0.600
Why?
Meningitis, Meningococcal
1
2018
7
0.600
Why?
Respiratory Tract Infections
3
2023
50
0.600
Why?
Haemophilus Infections
2
2017
5
0.590
Why?
Mothers
3
2023
106
0.590
Why?
Severity of Illness Index
3
2024
455
0.570
Why?
Vaccine Potency
1
2017
4
0.570
Why?
Encephalomyelitis, Acute Disseminated
2
2016
4
0.570
Why?
Status Asthmaticus
1
2017
1
0.570
Why?
Immunization, Passive
1
2017
3
0.560
Why?
Tetanus Toxoid
5
2018
11
0.540
Why?
Myelitis, Transverse
1
2016
4
0.540
Why?
Schools
6
2025
87
0.540
Why?
Optic Neuritis
1
2016
3
0.530
Why?
Hearing Loss, Sudden
1
2016
1
0.530
Why?
Research Design
1
2018
376
0.530
Why?
Health Knowledge, Attitudes, Practice
7
2022
382
0.520
Why?
Serogroup
3
2021
10
0.510
Why?
Infant, Extremely Low Birth Weight
1
2015
3
0.500
Why?
Intubation, Intratracheal
1
2015
6
0.500
Why?
Health Policy
3
2022
123
0.500
Why?
Bell Palsy
2
2012
14
0.500
Why?
Respiration, Artificial
1
2015
37
0.490
Why?
Databases, Factual
7
2025
315
0.490
Why?
Odds Ratio
7
2023
673
0.480
Why?
Papillomaviridae
2
2020
58
0.460
Why?
Age Factors
9
2021
923
0.460
Why?
Hepatitis B Vaccines
5
2020
43
0.460
Why?
Infant, Small for Gestational Age
5
2017
57
0.450
Why?
Chronic Disease
2
2016
428
0.450
Why?
Hepatitis A Vaccines
4
2019
14
0.450
Why?
Population Surveillance
4
2025
264
0.440
Why?
Chickenpox
2
2020
35
0.440
Why?
Respiratory Syncytial Virus Infections
2
2024
29
0.440
Why?
Penile Diseases
1
2013
1
0.440
Why?
Urethral Diseases
1
2013
1
0.440
Why?
Vulvar Diseases
1
2013
1
0.440
Why?
Uterine Cervical Diseases
1
2013
2
0.430
Why?
Vaginal Diseases
1
2013
6
0.430
Why?
Proportional Hazards Models
5
2023
711
0.430
Why?
Condylomata Acuminata
1
2013
23
0.430
Why?
Skin Diseases, Bacterial
1
2012
5
0.420
Why?
Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18
4
2017
32
0.420
Why?
Syncope
1
2012
12
0.410
Why?
Intussusception
4
2014
16
0.410
Why?
Mandatory Programs
2
2025
6
0.410
Why?
Critical Illness
2
2023
50
0.410
Why?
Apnea
2
2010
3
0.390
Why?
Health Personnel
1
2013
126
0.380
Why?
Uterine Cervical Neoplasms
4
2022
125
0.380
Why?
Immunologic Memory
2
2013
3
0.370
Why?
Metabolism, Inborn Errors
1
2011
2
0.370
Why?
Vaccines, Acellular
5
2020
11
0.370
Why?
Database Management Systems
3
2020
14
0.370
Why?
Rotavirus
2
2021
18
0.360
Why?
Parents
4
2022
297
0.360
Why?
Insurance, Health
3
2021
183
0.360
Why?
Biomedical Research
1
2011
86
0.350
Why?
T-Lymphocytes
1
2010
8
0.340
Why?
Pamphlets
1
2009
7
0.340
Why?
Diabetes Mellitus, Type 1
2
2021
121
0.330
Why?
Patient Discharge
1
2011
154
0.330
Why?
Rotavirus Infections
3
2021
31
0.330
Why?
Immunocompromised Host
2
2021
18
0.330
Why?
Viral Vaccines
2
2023
12
0.320
Why?
src-Family Kinases
2
1999
2
0.310
Why?
Congenital Abnormalities
3
2017
26
0.310
Why?
Prospective Studies
10
2023
1286
0.310
Why?
CD4-Positive T-Lymphocytes
2
2017
14
0.300
Why?
Epidemiologic Methods
2
2017
81
0.290
Why?
Electronic Health Records
6
2023
698
0.280
Why?
Respiratory Syncytial Virus, Human
2
2024
21
0.270
Why?
Patient Acceptance of Health Care
2
2020
391
0.270
Why?
CD8-Positive T-Lymphocytes
1
2006
5
0.260
Why?
Surveys and Questionnaires
5
2025
1323
0.260
Why?
Venous Thromboembolism
2
2017
53
0.260
Why?
Cross-Sectional Studies
8
2024
1335
0.250
Why?
Immunoglobulin G
4
2021
29
0.250
Why?
HIV Infections
2
2024
707
0.240
Why?
Educational Personnel
1
2025
1
0.240
Why?
Aluminum
2
2022
14
0.240
Why?
Bacterial Capsules
2
2017
5
0.240
Why?
Delivery of Health Care, Integrated
5
2024
537
0.240
Why?
Treatment Outcome
3
2021
1265
0.240
Why?
Respiratory Syncytial Virus Vaccines
1
2024
8
0.230
Why?
Influenza A Virus, H3N2 Subtype
1
2024
15
0.230
Why?
Gonorrhea
1
2024
18
0.230
Why?
Chlamydia Infections
1
2024
25
0.230
Why?
Animals
3
2020
262
0.220
Why?
Mortality
2
2021
118
0.210
Why?
Polyradiculoneuropathy, Chronic Inflammatory Demyelinating
1
2022
4
0.210
Why?
Poisson Distribution
4
2016
88
0.210
Why?
Polymerase Chain Reaction
2
2013
49
0.210
Why?
Respiratory Tract Diseases
2
2020
25
0.210
Why?
Pharyngitis
1
2022
10
0.210
Why?
Sex Factors
3
2021
644
0.210
Why?
Intention
1
2022
28
0.210
Why?
Eczema
1
2022
7
0.210
Why?
School Health Services
2
2021
39
0.210
Why?
Practice Guidelines as Topic
2
2021
321
0.200
Why?
Confidence Intervals
3
2021
237
0.200
Why?
Pregnant Women
2
2020
45
0.190
Why?
China
1
2022
132
0.190
Why?
Hepatitis A
2
2019
10
0.190
Why?
Intensive Care Units
2
2024
105
0.190
Why?
Centers for Disease Control and Prevention (U.S.)
4
2014
32
0.190
Why?
Trans-Activators
2
1999
8
0.190
Why?
Antibodies, Neutralizing
1
2021
6
0.190
Why?
ras Proteins
2
1999
20
0.190
Why?
Physicians, Primary Care
1
2022
72
0.190
Why?
Inflammatory Bowel Diseases
1
2021
17
0.190
Why?
Regression Analysis
3
2016
300
0.180
Why?
Heptavalent Pneumococcal Conjugate Vaccine
3
2021
15
0.180
Why?
Nervous System Diseases
2
2011
19
0.180
Why?
Circovirus
1
2020
1
0.180
Why?
Mental Disorders
1
2024
280
0.180
Why?
Spatial Analysis
1
2020
11
0.180
Why?
Geography
1
2020
39
0.180
Why?
Linguistics
1
2020
5
0.180
Why?
Pregnancy Trimester, First
2
2017
40
0.170
Why?
Prognosis
2
2020
609
0.170
Why?
Complement System Proteins
2
2018
4
0.170
Why?
Europe
1
2020
42
0.170
Why?
Education
1
2020
17
0.170
Why?
Bacterial Infections
1
2019
9
0.170
Why?
Professional-Family Relations
1
2020
49
0.170
Why?
Diphtheria Toxoid
2
2017
3
0.170
Why?
Epidemiological Monitoring
1
2019
25
0.170
Why?
Virus Replication
1
1999
13
0.170
Why?
Bacterial Vaccines
2
2023
9
0.170
Why?
Hepatitis A Virus, Human
1
2019
5
0.170
Why?
Hepatitis B virus
1
1999
20
0.170
Why?
Coronavirus Infections
1
2020
49
0.170
Why?
Pneumonia, Viral
1
2020
56
0.170
Why?
Frail Elderly
1
2019
9
0.160
Why?
Frailty
1
2019
10
0.160
Why?
History, 21st Century
2
2019
24
0.160
Why?
Qualitative Research
1
2020
256
0.160
Why?
Outcome Assessment (Health Care)
2
2018
228
0.160
Why?
Epidemiologic Research Design
2
2016
18
0.160
Why?
Gestational Age
3
2021
112
0.150
Why?
Hispanic Americans
1
2020
404
0.150
Why?
Models, Theoretical
1
2018
70
0.150
Why?
Rabbits
1
2018
6
0.150
Why?
Residence Characteristics
1
2020
251
0.150
Why?
Infant Mortality
1
2018
20
0.150
Why?
Vaccines, Subunit
1
2017
1
0.150
Why?
Microcephaly
1
2017
3
0.150
Why?
Respiratory Distress Syndrome, Newborn
1
2017
6
0.150
Why?
Bordetella pertussis
2
2020
4
0.150
Why?
Adjuvants, Immunologic
1
2017
16
0.150
Why?
Multivariate Analysis
4
2017
569
0.150
Why?
Abnormalities, Drug-Induced
1
2017
15
0.150
Why?
Licensure
1
2017
5
0.150
Why?
Infant, Very Low Birth Weight
1
2017
10
0.140
Why?
Uterine Cervical Dysplasia
1
2017
8
0.140
Why?
African Americans
1
2020
472
0.140
Why?
Haemophilus influenzae type b
1
2017
2
0.140
Why?
Preconception Care
1
2017
44
0.140
Why?
Safety Management
3
2011
14
0.140
Why?
Patient Compliance
1
2019
301
0.140
Why?
Decision Making
1
2018
184
0.140
Why?
Health Maintenance Organizations
2
2010
417
0.140
Why?
Infant, Newborn, Diseases
1
2017
35
0.140
Why?
Family Health
1
2017
44
0.140
Why?
Pregnancy Complications
2
2017
201
0.130
Why?
Maternal Age
3
2023
77
0.130
Why?
Pandemics
3
2024
287
0.130
Why?
Liver Diseases
1
2016
23
0.130
Why?
Epidemiologic Studies
1
2016
29
0.130
Why?
Anaphylaxis
1
2015
15
0.130
Why?
Autistic Disorder
1
2017
100
0.120
Why?
Causality
2
2012
40
0.120
Why?
Double-Blind Method
3
2021
160
0.120
Why?
Immunity, Cellular
2
2017
4
0.120
Why?
Comorbidity
4
2022
597
0.120
Why?
Biomarkers, Pharmacological
1
2015
5
0.120
Why?
Sex Distribution
2
2017
190
0.120
Why?
Communicable Diseases, Emerging
1
2014
1
0.120
Why?
Prenatal Exposure Delayed Effects
1
2017
167
0.120
Why?
History, 20th Century
1
2014
10
0.120
Why?
Treatment Refusal
1
2015
33
0.120
Why?
Age Distribution
2
2017
246
0.120
Why?
Mucocutaneous Lymph Node Syndrome
1
2014
18
0.120
Why?
Algorithms
2
2017
239
0.120
Why?
Medical Records
2
2017
100
0.120
Why?
DiGeorge Syndrome
1
2014
2
0.110
Why?
Safety
2
2011
41
0.110
Why?
Pulmonary Disease, Chronic Obstructive
1
2016
197
0.110
Why?
Hypertension, Pregnancy-Induced
1
2014
46
0.110
Why?
Opsonin Proteins
1
2013
1
0.110
Why?
Phagocytosis
1
2013
2
0.110
Why?
Health Education
2
2011
111
0.110
Why?
Attitude to Health
1
2015
165
0.110
Why?
Sexually Transmitted Diseases, Viral
1
2013
2
0.110
Why?
Gastrointestinal Diseases
1
2013
27
0.110
Why?
Carcinoma in Situ
1
2013
17
0.110
Why?
Cervical Intraepithelial Neoplasia
1
2013
16
0.110
Why?
Alphapapillomavirus
1
2013
13
0.100
Why?
Graves Disease
1
2012
3
0.100
Why?
Drug Evaluation
1
2012
6
0.100
Why?
Hospital Mortality
2
2023
145
0.100
Why?
Stroke
2
2019
315
0.100
Why?
Laboratories
2
2021
18
0.100
Why?
Prevalence
4
2017
888
0.100
Why?
Advisory Committees
2
2024
113
0.100
Why?
Adenocarcinoma
1
2013
173
0.090
Why?
Arthritis, Rheumatoid
1
2011
23
0.090
Why?
Information Services
1
2011
16
0.090
Why?
Reference Values
1
2011
93
0.090
Why?
Needs Assessment
1
2011
69
0.090
Why?
Length of Stay
1
2011
182
0.090
Why?
Hematologic Diseases
1
2010
3
0.090
Why?
Anti-Bacterial Agents
2
2022
142
0.090
Why?
Hypersensitivity
1
2010
18
0.090
Why?
Antipyretics
1
2010
4
0.090
Why?
Physical Examination
1
2010
20
0.090
Why?
Flow Cytometry
1
2010
5
0.090
Why?
Monocytes
1
2010
5
0.090
Why?
Medical Audit
1
2010
39
0.090
Why?
Information Systems
1
2009
22
0.080
Why?
Public Health Surveillance
2
2019
42
0.080
Why?
Longitudinal Studies
2
2014
720
0.080
Why?
Enzyme Activation
2
1999
6
0.080
Why?
Brain Ischemia
1
2009
37
0.080
Why?
Signal Transduction
2
1999
30
0.080
Why?
Mumps Vaccine
1
2008
7
0.080
Why?
Rubella Vaccine
1
2008
8
0.080
Why?
Poliomyelitis
1
2008
2
0.080
Why?
Bias
2
2020
103
0.070
Why?
Medicaid
2
2025
190
0.070
Why?
Serotyping
1
2007
3
0.070
Why?
Sentinel Surveillance
1
2007
12
0.070
Why?
Injections, Intramuscular
2
2021
10
0.070
Why?
Diseases in Twins
1
2007
15
0.070
Why?
Twins
1
2007
12
0.070
Why?
Siblings
1
2007
12
0.070
Why?
Predictive Value of Tests
1
2008
354
0.070
Why?
Medication Adherence
1
2009
246
0.070
Why?
Single-Blind Method
2
2020
45
0.070
Why?
Mass Vaccination
2
2019
22
0.070
Why?
Interferon-gamma
1
2006
8
0.070
Why?
Propensity Score
2
2017
85
0.070
Why?
Sex Characteristics
1
2006
69
0.060
Why?
Drug Administration Schedule
2
2020
100
0.060
Why?
Registries
1
2008
472
0.060
Why?
International Classification of Diseases
2
2017
85
0.060
Why?
Genetic Predisposition to Disease
1
2007
376
0.060
Why?
Toxoids
1
2023
3
0.050
Why?
Oxygen
1
2023
16
0.050
Why?
Macrolides
1
2022
7
0.050
Why?
Penicillins
1
2022
6
0.050
Why?
Inappropriate Prescribing
1
2022
8
0.050
Why?
Early Detection of Cancer
2
2022
513
0.050
Why?
RNA, Messenger, Stored
1
2022
3
0.050
Why?
Electronics
1
2022
4
0.050
Why?
Human papillomavirus 18
1
2022
3
0.050
Why?
Human papillomavirus 16
1
2022
7
0.050
Why?
Alberta
1
2021
3
0.050
Why?
Antiviral Agents
1
2022
95
0.050
Why?
Antigens
1
2021
7
0.050
Why?
Postal Service
1
2022
73
0.050
Why?
Drug Approval
1
2021
12
0.050
Why?
Forecasting
1
2022
75
0.050
Why?
Data Interpretation, Statistical
1
2021
77
0.050
Why?
Drug Prescriptions
1
2022
151
0.050
Why?
Systemic Inflammatory Response Syndrome
1
2021
9
0.050
Why?
Ambulatory Care Facilities
1
2021
69
0.050
Why?
Pain
1
2021
79
0.040
Why?
Policy
1
2020
18
0.040
Why?
National Institute of Allergy and Infectious Diseases (U.S.)
1
2020
1
0.040
Why?
Perception
1
2021
58
0.040
Why?
Child Health Services
1
2022
113
0.040
Why?
Health Facilities
1
2020
17
0.040
Why?
Attitude
1
2020
30
0.040
Why?
Global Health
1
2020
33
0.040
Why?
Disease Susceptibility
1
2020
37
0.040
Why?
Managed Care Programs
2
2013
325
0.040
Why?
Drug Hypersensitivity
1
2019
10
0.040
Why?
Appendicitis
1
2019
15
0.040
Why?
Hepatitis B Virus, Woodchuck
1
1999
1
0.040
Why?
Viral Proteins
1
1999
2
0.040
Why?
DNA Primers
1
1999
7
0.040
Why?
Cell Line
1
1999
10
0.040
Why?
Base Sequence
1
1999
19
0.040
Why?
Practice Patterns, Physicians'
1
2022
332
0.040
Why?
Health Status Disparities
1
2021
147
0.040
Why?
RNA, Viral
1
1999
65
0.040
Why?
Continental Population Groups
1
2021
302
0.040
Why?
Cerebrovascular Disorders
1
2019
34
0.040
Why?
Pancreatitis
1
2019
50
0.040
Why?
Mass Screening
1
2024
678
0.040
Why?
Viral Load
1
2019
136
0.040
Why?
Respiratory Sounds
1
2018
12
0.040
Why?
Hepatitis B
1
2018
42
0.040
Why?
Adjuvants, Pharmaceutic
1
2017
1
0.040
Why?
Viral Envelope Proteins
1
2017
2
0.040
Why?
Immunity, Humoral
1
2017
4
0.040
Why?
Guanosine Triphosphate
1
1997
1
0.040
Why?
Transcriptional Activation
1
1997
1
0.040
Why?
3T3 Cells
1
1997
1
0.040
Why?
Transcription Factor AP-1
1
1997
1
0.040
Why?
GTPase-Activating Proteins
1
1997
1
0.040
Why?
ras GTPase-Activating Proteins
1
1997
1
0.040
Why?
Viral Regulatory and Accessory Proteins
1
1997
1
0.040
Why?
Ethnic Groups
1
2021
485
0.040
Why?
Proteins
1
1997
16
0.040
Why?
Mice
1
1997
69
0.040
Why?
Venous Thrombosis
1
2017
21
0.040
Why?
Equivalence Trials as Topic
1
2017
1
0.040
Why?
Infant, Low Birth Weight
1
2017
35
0.040
Why?
Influenza B virus
1
2017
9
0.040
Why?
Pulmonary Embolism
1
2017
44
0.030
Why?
Cause of Death
1
2018
181
0.030
Why?
Proof of Concept Study
1
2016
3
0.030
Why?
Dose-Response Relationship, Drug
1
2017
129
0.030
Why?
Child Development Disorders, Pervasive
1
2017
33
0.030
Why?
Pregnancy Trimesters
1
2016
30
0.030
Why?
Observational Studies as Topic
1
2016
47
0.030
Why?
Postpartum Period
1
2016
97
0.030
Why?
Topography, Medical
1
2015
5
0.030
Why?
Utilization Review
1
2015
53
0.030
Why?
Vasculitis
1
2014
2
0.030
Why?
Contraindications
1
2014
14
0.030
Why?
Cooperative Behavior
1
2014
92
0.030
Why?
Emergency Medical Services
1
2013
48
0.030
Why?
Papanicolaou Test
1
2013
37
0.030
Why?
Neoplasm Grading
1
2013
49
0.030
Why?
Vaginal Smears
1
2013
48
0.030
Why?
Vaccines, Live, Unattenuated
1
2012
1
0.030
Why?
Narcolepsy
1
2012
6
0.030
Why?
Cranial Nerve Diseases
1
2011
2
0.020
Why?
Hepatitis A Antibodies
1
2011
2
0.020
Why?
Monitoring, Immunologic
1
2011
4
0.020
Why?
Role
1
2011
3
0.020
Why?
Tennessee
1
2011
6
0.020
Why?
Recurrence
1
2012
189
0.020
Why?
Comprehension
1
2011
17
0.020
Why?
Culture
1
2011
26
0.020
Why?
Academic Medical Centers
1
2011
30
0.020
Why?
Bacterial Proteins
1
2010
13
0.020
Why?
Randomized Controlled Trials as Topic
1
2012
329
0.020
Why?
Referral and Consultation
1
2011
169
0.020
Why?
Concepts (458)
Explore
_
Co-Authors (28)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_
Physical Neighbors
_
-->

© 2025 Kaiser Permanente